| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.068 | 0.3 |